Kymera Therapeutics Trades Flat Near 81 as Biotechnology Sector Awaits Catalysts AppLovin Shares Surge Over 10 Following Bullish Analyst Upgrade and Price Target Increase TRP Q1 2026 Earnings Slight EPS Miss Clouds Outlook as Revenue Details Remain Unreported Traders Question Irans Timeline for Strait of Hormuz Reopening Amid Peace Deal Reports